Healthcare provider profile · identity verified

Bobbie Jo Sperry, M.D.

Family Practice · HAMPTON, VA · NPI 1164623872

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	348	105
Amlodipine Besylate	Amlodipine Besylate	216	68
Levothyroxine Sodium	Levothyroxine Sodium	212	62
Lisinopril	Lisinopril	194	63
Omeprazole	Omeprazole	171	60
Simvastatin	Simvastatin	139	45
Rosuvastatin Calcium	Rosuvastatin Calcium	133	41
Losartan Potassium	Losartan Potassium	125	36
Montelukast Sodium	Montelukast Sodium	125	38
Metformin Hcl	Metformin Hcl	115	36
Metoprolol Succinate	Metoprolol Succinate	104	32
Allopurinol	Allopurinol	93	26
Famotidine	Famotidine	92	34
Hydrochlorothiazide	Hydrochlorothiazide	90	30
Synthroid	Levothyroxine Sodium	84	22
Pravastatin Sodium	Pravastatin Sodium	80	28
Pantoprazole Sodium	Pantoprazole Sodium	76	24
Albuterol Sulfate Hfa	Albuterol Sulfate	70	37
Alendronate Sodium	Alendronate Sodium	63	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	15
Gabapentin	Gabapentin	62	24
Tamsulosin Hcl	Tamsulosin Hcl	62	22
Prednisone	Prednisone	60	45
Sertraline Hcl	Sertraline Hcl	58	19
Glipizide Er	Glipizide	57	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	13
Metoprolol Tartrate	Metoprolol Tartrate	54	20
Furosemide	Furosemide	53	21
Ozempic	Semaglutide	53	suppressed
Valsartan	Valsartan	52	14
Carvedilol	Carvedilol	51	14
Trazodone Hcl	Trazodone Hcl	50	15
Escitalopram Oxalate	Escitalopram Oxalate	45	16
Spironolactone	Spironolactone	43	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	13
Clonazepam	Clonazepam	40	suppressed
Metformin Hcl Er	Metformin Hcl	38	12
Trulicity	Dulaglutide	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Ezetimibe	Ezetimibe	36	11
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Eliquis	Apixaban	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	14
Atenolol	Atenolol	33	11
Azithromycin	Azithromycin	33	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	15
Meloxicam	Meloxicam	33	16
Lorazepam	Lorazepam	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Ondansetron Odt	Ondansetron	28	15
Alprazolam	Alprazolam	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	25
Tramadol Hcl	Tramadol Hcl	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Methylprednisolone	Methylprednisolone	26	26
Doxepin Hcl	Doxepin Hcl	25	suppressed
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Lovastatin	Lovastatin	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	18
Azelastine Hcl	Azelastine Hcl	22	suppressed
Estradiol	Estradiol	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	11
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Amoxicillin	Amoxicillin	19	17
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	19	16
Temazepam	Temazepam	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Jardiance	Empagliflozin	18	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Nystatin	Nystatin	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Donepezil Hcl	Donepezil Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	13	13
Topiramate	Topiramate	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Cabergoline	Cabergoline	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Diazepam	Diazepam	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Lipitor	Atorvastatin Calcium	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error